(Q34259426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

review article

0 references

title

Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Paul Sandor

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Tamara Pringsheim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Daniel Gorman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Duncan McKinlay

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Lundy Day

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Lori Billinghurst

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Alan Carroll

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Yves Dion

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Sandra Luscombe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Thomas Steeves

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

1 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Psychiatry

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

133-143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Current methods of the US Preventive Services Task Force: a review of the process

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Pimozide for tics in Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Treatment approaches in Gilles de la Tourette syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Metoclopramide-induced tardive dyskinesia in an infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

A placebo-controlled trial of risperidone in Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Quetiapine treatment of children and adolescents with Tourette's disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Clonidine treatment of Gilles de la Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Short- and long-term treatment of Tourette's syndrome with clonidine: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Treatment of ADHD in children with tics: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Neuropsychiatric effects of guanfacine in children with mild tourette syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Adverse reactions to new anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Topiramate-associated acute, bilateral, secondary angle-closure glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Botulinum toxin in the treatment of dystonic tics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Botulinum toxin in the treatment of tics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Cannabinoids for Tourette's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Ropinirole in Gilles de la Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Clinical and attentional effects of acute nicotine treatment in Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Traditional Chinese medicine Ningdong granule: the beneficial effects in Tourette's disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Clinical observation on treatment of Tourette syndrome by integrative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Brief report: effects of propranolol in Tourette syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

Clinical course of Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371205700302

10.1177/070674371205700302

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22397999%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference